| 000 | 01070 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517175832.0 | ||
| 264 | 0 | _c20190508 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1555-7162 | ||
| 024 | 7 |
_a10.1016/j.amjmed.2017.09.014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNodzynski, Thomas | |
| 245 | 0 | 0 |
_aA Rose by Any Other Name: Ketoacidosis Due to SGLT2 Inhibitors Reveals Latent Autoimmune Diabetes. _h[electronic resource] |
| 260 |
_bThe American journal of medicine _cJan 2018 |
||
| 300 |
_ae1-e3 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aDiabetic Ketoacidosis _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLatent Autoimmune Diabetes in Adults _xcomplications |
| 650 | 0 | 4 |
_aSodium-Glucose Transporter 2 Inhibitors _xadverse effects |
| 700 | 1 | _aLee, Todd C | |
| 773 | 0 |
_tThe American journal of medicine _gvol. 131 _gno. 1 _gp. e1-e3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.amjmed.2017.09.014 _zAvailable from publisher's website |
| 999 |
_c27636026 _d27636026 |
||